Publications by authors named "Magali Olivier"

53Publications

Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants.

Hum Mutat 2018 08 5;39(8):1061-1069. Epub 2018 Jun 5.

QIMR Berghofer Medical Research Institute, Genetics and Computational Division, Herston, Queensland, Australia.

View Article and Find Full Text PDF
August 2018

Genome Sequence of a Novel Human Gammapapillomavirus Isolated from Skin.

Genome Announc 2017 Jun 8;5(23). Epub 2017 Jun 8.

Infections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France

View Article and Find Full Text PDF
June 2017

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.

Hum Mutat 2016 09 8;37(9):865-76. Epub 2016 Jul 8.

Group of Molecular Mechanisms and Biomarkers, International Agency for Research on Cancer, Lyon Cedex 08, 69372, France.

View Article and Find Full Text PDF
September 2016

MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes.

BMC Bioinformatics 2016 Apr 18;17:170. Epub 2016 Apr 18.

Molecular Mechanisms and Biomarkers Group, International Agency for Research on Cancer, F69372, Lyon, France.

View Article and Find Full Text PDF
April 2016

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.

Eur Respir J 2015 Dec 22;46(6):1773-80. Epub 2015 Oct 22.

Department of Acute Respiratory Medicine and Thoracic Oncology Department, Lyon Sud Hospital and Lyon University Cancer Institute, Lyon University Hospital, Pierre Bénite, France EMR 3738 "Therapeutic Targeting in Oncology", Lyon Sud - Charles Mérieux Faculty of Medicine, Lyon 1 University, Oullins, France

View Article and Find Full Text PDF
December 2015

Upper urinary tract urothelial cancers: where it is A:T.

Nat Rev Cancer 2012 08;12(8):503-4

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon, France.

View Article and Find Full Text PDF
August 2012

Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma.

Sarcoma 2012 7;2012:492086. Epub 2012 Mar 7.

Division of Pediatric Epidemiology and Clinical Research, University of Minnesota, 420 Delaware Street SE, MMC 422, Minneapolis, MN 55455, USA.

View Article and Find Full Text PDF
August 2012

Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.

Cancer 2012 Mar 11;118(5):1387-96. Epub 2011 Aug 11.

Division of Pediatric Epidemiology and Clinical Research, University of Minnesota, Minneapolis, Minnesota, USA.

View Article and Find Full Text PDF
March 2012

Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes.

Curr Opin Oncol 2011 Jan;23(1):88-92

International Agency for Research on Cancer, Group of Molecular Carcinogenesis, Lyon, France.

View Article and Find Full Text PDF
January 2011

Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines.

Breast Cancer Res Treat 2011 Jan 11;125(1):35-42. Epub 2010 Mar 11.

Molecular Carcinogenesis Group, International Agency for Research on Cancer, Lyon, France.

View Article and Find Full Text PDF
January 2011

TP53 mutations in human cancers: origins, consequences, and clinical use.

Cold Spring Harb Perspect Biol 2010 Jan;2(1):a001008

Group of Molecular Carcinogenesis, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France.

View Article and Find Full Text PDF
January 2010

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck.

Clin Cancer Res 2009 Dec;15(24):7719-7725

Authors' Affiliations: Mary Crowley Cancer Research Centers, Dallas, Texas; The University of Texas M.D. Anderson Cancer Center; Introgen Therapeutics, Houston, Texas; St. Luke's Cancer Center, Bethlehem, Pennsylvania; WJB Dorn Veterans Affairs Medical Center, Columbia, South Carolina; Emory University School of Medicine, Atlanta, Georgia; University of Louisville, Louisville, Kentucky; Wayne State University, Detroit, Michigan; Hospital General Universitario Vall d' Hebron, Barcelona, Spain; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; University of Illinois, Chicago, Illinois; IARC, Lyon, France; and University of Miami Sylvester Cancer Center, Miami, Florida.

View Article and Find Full Text PDF
December 2009

Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.

Curr Opin Oncol 2010 Jan;22(1):64-9

International Agency for Research on Cancer, Group of Molecular Carcinogenesis, Lyon, France.

View Article and Find Full Text PDF
January 2010

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.

Hum Mutat 2007 Jun;28(6):622-9

Group of Molecular Carcinogenesis and Biomarkers, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.

View Article and Find Full Text PDF
June 2007

Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations.

Hum Mutat 2006 Feb;27(2):163-72

Department of Bioinformatics and Computational Biology, George Mason University, Manassas, Virginia, USA.

View Article and Find Full Text PDF
February 2006

TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives.

Mutat Res 2005 May 31;589(3):192-207. Epub 2005 Mar 31.

Departamento de Biologia Celular e Genética, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.

View Article and Find Full Text PDF
May 2005

TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.

IARC Sci Publ 2004 (157):247-70

Laboratory of Human Carcinogenesis, Division of Cancer Etiology, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article and Find Full Text PDF
April 2004

Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.

Oncogene 2002 Oct;21(48):7435-51

Division of Biology, Beckman Research Institute of the City of Hope, Duarte, California, CA 91010, USA.

View Article and Find Full Text PDF
October 2002

Differential activation of p53 by the various adducts of mitomycin C.

J Biol Chem 2002 Oct 14;277(43):40513-9. Epub 2002 Aug 14.

Department of Biological Sciences, Institute for Biomolecular Structure and Function, Hunter College and Graduate School, CUNY, New York, NY 10021, USA.

View Article and Find Full Text PDF
October 2002

The IARC TP53 database: new online mutation analysis and recommendations to users.

Hum Mutat 2002 Jun;19(6):607-14

Molecular Carcinogenesis Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.

View Article and Find Full Text PDF
June 2002